In another report, compromised FcγR binding activities against different spike variants of concern were observed in convalescent COVID-19 patients as compared with LNP-mRNA vaccine recipients, and the differences were ascribed to lower antibody quantities present in the convalescent samples (33). The gene discussed is FCGR2A; the disease is COVID-19.